Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $105.91.
A number of brokerages have recently issued reports on MMSI. Weiss Ratings upgraded Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, October 12th. Needham & Company LLC raised their price target on shares of Merit Medical Systems from $101.00 to $106.00 and gave the company a “buy” rating in a report on Friday, October 30th. Robert W. Baird set a $98.00 price target on shares of Merit Medical Systems in a research report on Friday, July 31st. JPMorgan Chase & Co. lifted their price target on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a research report on Friday, October 30th. Finally, Raymond James Financial set a $104.00 price objective on shares of Merit Medical Systems and gave the stock an “outperform” rating in a research note on Monday.
View Our Latest Analysis on MMSI
Insider Activity at Merit Medical Systems
In related news, insider Brian Lloyd sold 16,722 shares of Merit Medical Systems stock in a transaction on Monday, November 16th. The shares were sold at an average price of $86.33, for a total transaction of $1,443,610.26. Following the transaction, the insider owned 60,132 shares in the company, valued at approximately $5,191,195.56. The trade was a 21.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.70% of the company’s stock.
Institutional Trading of Merit Medical Systems
Large investors have recently added to or reduced their stakes in the stock. Zacks Investment Management purchased a new position in Merit Medical Systems in the third quarter valued at about $536,000. Integrated Wealth Concepts LLC lifted its stake in shares of Merit Medical Systems by 7.7% during the third quarter. Integrated Wealth Concepts LLC now owns 3,086 shares of the medical instruments supplier’s stock worth $266,000 after purchasing an additional 220 shares in the last quarter. Allworth Financial LP lifted its stake in shares of Merit Medical Systems by 16.3% during the third quarter. Allworth Financial LP now owns 2,232 shares of the medical instruments supplier’s stock worth $192,000 after purchasing an additional 312 shares in the last quarter. Pure Financial Advisors LLC boosted its position in shares of Merit Medical Systems by 7.3% in the third quarter. Pure Financial Advisors LLC now owns 4,358 shares of the medical instruments supplier’s stock worth $376,000 after buying an additional 296 shares during the period. Finally, Aquatic Capital Management LLC purchased a new stake in shares of Merit Medical Systems in the third quarter worth about $180,000. 99.66% of the stock is currently owned by institutional investors and hedge funds.
Merit Medical Systems Price Performance
Shares of Merit Medical Systems stock opened at $85.93 on Monday. Merit Medical Systems has a twelve month low of $59.74 and a twelve month high of $94.85. The stock has a market capitalization of $5.15 billion, a P/E ratio of 21.72, a PEG ratio of 2.06 and a beta of 0.56. The company has a current ratio of 4.52, a quick ratio of 3.05 and a debt-to-equity ratio of 0.42. The business’s fifty day moving average price is $87.87 and its 200 day moving average price is $77.48.
Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, topping the consensus estimate of $1.04 by $0.08. The company had revenue of $416.24 million during the quarter, compared to analyst estimates of $410.56 million. Merit Medical Systems had a return on equity of 14.12% and a net margin of 9.94%. The firm’s revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.92 earnings per share. As a group, research analysts anticipate that Merit Medical Systems will post 3.86 earnings per share for the current year.
About Merit Medical Systems
Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.
See Also
- Five stocks we like better than Merit Medical Systems
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
